Rhoen Klinikum AG (RKAGY)
6.05
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 809.96M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -13.40% |
Valuation | |
PE Ratio | 19.28 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.5098 |
Price to Book Value | 0.5852 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.0811 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.1141 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 66.18% |
Profile
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue. |
URL | https://www.rhoen-klinikum-ag.com |
Investor Relations URL | https://en.rhoen-klinikum-ag.com/investor-relations.html |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 10, 2024 (est.) |
Last Earnings Release | Nov. 09, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jun. 08, 2023 |
Ratings
Profile
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue. |
URL | https://www.rhoen-klinikum-ag.com |
Investor Relations URL | https://en.rhoen-klinikum-ag.com/investor-relations.html |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 10, 2024 (est.) |
Last Earnings Release | Nov. 09, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jun. 08, 2023 |